The recent development of the MiCBO-TF model, a fusion of human microglia-containing brain organoids with H3K27M-mutant DMG spheroids, enables the dynamic study of tumor infiltration and microglia behavior, offering a powerful preclinical platform to investigate therapeutic responses in a physiologically relevant tumor–immune microenvironment [241,242]. Here, TF is linked to neoplasm.